Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study

Phase 4 Completed 20 enrolled University of California, Davis Merck Sharp & Dohme LLC · collab

NaSingle-groupOpen-labelPrevention

Summary

Women currently using or starting a combined oral contraceptive will be offered study enrollment. Study subjects will have a Nexplanon placed and followed for 6 months to evaluate if they continue the COC, continue the implant, or both, and to assess adverse events and bleeding patterns.

Timeline

Start: 2016-09-15
Primary completion: 2017-07-26
Completion: 2017-07-26

Publications

Chen MJ, Hsia JK, Creinin MD. Etonogestrel implant use in women primarily choosing a combined oral contraceptive pill: A proof-of-concept trial. Contraception. 2018 Jun;97(6):533-537. doi: 10.1016/j.contraception.2018.02.009. Epub 2018 Feb 26.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Etonogestrel	Unknown	—	Other

Indications

No indication recorded.